CAN
SRNE

Cetera Advisor Networks’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Cetera Advisor Networks’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,762
Closed -$15.7K – 2702
2022
Q4 		$15.7K Sell
17,762
-7,118
-29% -$9.44K ﹤0.01% 2494
2022
Q3 		$39K Buy
24,880
+2,425
+11% +$5.5K ﹤0.01% 2028
2022
Q2 		$45K Buy
22,455
+3,800
+20% +$6.57K ﹤0.01% 2008
2022
Q1 		$43K Buy
18,655
+1,000
+6% +$3.12K ﹤0.01% 2023
2021
Q4 		$82K Buy
+17,655
New +$110K ﹤0.01% 1979
2020
Q3 		– Sell
-8,250
Closed -$52K – 3233
2020
Q2 		$52K Buy
+8,250
New +$31.6K ﹤0.01% 1875

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Cetera Advisor Networks's SRNE Position: Q1 2023 in Review

Cetera Advisor Networks sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 17,762 shares — an estimated $15.7K sold.

Cetera Advisor Networks first reported a position in SRNE in Q2 2020 and held it in 6 quarters. The position peaked at $82K in Q4 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Cetera Advisor Networks reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Cetera Advisor Networks sold 17,762 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $15.7K.
  • Cetera Advisor Networks first reported a position in Sorrento Therapeutics, Inc. in Q2 2020 and held it in 6 quarters.
  • Cetera Advisor Networks's Sorrento Therapeutics, Inc. position peaked at $82K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Cetera Advisor Networks's 13F filing for Q1 2023, filed 15 May 2023.